Service & Suppliers

Found 29,808 articles

• Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA

  1/4/2024

  Kuros Biosciences announced three advancements related to its MagnetOs portfolio of products: specifically positive results from the MAXA level 1 clinical trial comparing standalone MagnetOs to autograft in a real world patient population in the challenging posterolateral fusion procedure, and two 510 clearances from the U.S. Food and Drug Administration related to its MagnetOs family of products.

• Editas Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference

  1/3/2024

  Editas Medicine, Inc., a clinical-stage genome editing company, announced that the Company’s President and CEO Gilmore O’Neill, M.B., M.M.Sc., will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, 4:30 p.m. PT / 7:30 p.m. ET in San Francisco, CA.

• Bruker Acquires Electron Microscopy Company Nion

  1/3/2024

  Bruker announced that it has acquired Nion, a privately-held company that develops and manufactures innovative high-end scanning transmission electron microscopes.

• Enovis Completes Acquisition of LimaCorporate S.p.A

  1/3/2024

  Enovis™ Corporation an innovation-driven, medical technology growth company, announced that it closed the acquisition of LimaCorporate S.p.A., a privately held global orthopedic leader focused on restoring motion through an innovative portfolio of implant solutions.

• Introducing PillSafe(R), the New 'Smart' Pill Bottle for Prescription Medication

  1/3/2024

  PillSafe® uses new disruptive technology, a groundbreaking economical "smart" pill bottle for prescription drugs, designed by doctors to ensure safety and compliance with medication in the fight against addictive drugs.

• Sonendo Partners With BEST for Dentistry to Continue Expanding Access to the Innovative GentleWave® Procedure

  1/3/2024

  Sonendo, Inc. announced a partnership agreement with BEST for Dentistry, a dental services company focused on leveling the playing field for independent dental practices.

• OGM Added to International System for Human Cytogenomic Nomenclature

  1/3/2024

  Bionano Genomics, Inc., announced a publication outlining the addition of optical genome mapping to the International System for Human Cytogenomic Nomenclature.

• International Consortium Publishes Comprehensive Roadmap for the Clinical Implementation of OGM in Hematological Malignancy Applications

  1/3/2024

  Bionano Laboratories, a laboratory services business of Bionano Genomics, Inc., announced the publication of the first framework paper for the clinical adoption and implementation of the optical genome mapping workflow for hematological malignancy applications, a process utilized by Bionano Laboratories in the development of its laboratory developed test, marketed as OGM-Dx™ HemeOne.

• Mesa Labs Completes the Acquisition of GKE Science & Technology Co.

  1/3/2024

  Mesa Laboratories, Inc. announced the completed acquisition of GKE-GmbH’s sterilization indicators business and its accredited, independent testing lab SAL GmbH on October 16th, 2023.

• NorthStar Medical Radioisotopes and Curadh MTR Enter Strategic Collaboration Agreement for Development and Production of Actinium-225 (Ac-225)-based Therapeutic Radiopharmaceuticals for Treatment of Primary and Metastatic Solid Tumors

  1/3/2024

  NorthStar Medical Radioisotopes, LLC and Curadh MTR Inc. announced a long-term strategic collaboration to develop and produce novel radiopharmaceuticals for the diagnosis and treatment of solid tumor cancers.

• Merit Medical to Present at the J.P. Morgan 42nd Annual Healthcare Conference

  1/3/2024

  Merit Medical Systems, Inc. announced that Merit Chairman and CEO, Fred Lampropoulos, is scheduled to present at the J.P. Morgan 42nd Annual Healthcare Conference on January 8, 2024, at 4:30pm PT.

• Simulations Plus Announces Leadership Appointments Supporting Commitment to Clients and Driving Growth

  1/3/2024

  Simulations Plus, Inc. announced the following leadership changes effective January 3, 2024.

• Octapharma Announces Availability of Balfaxar® For Warfarin Reversal in Urgent Surgery & Invasive Procedures

  1/3/2024

  Octapharma USA has announced Balfaxar® is now available. The new non-activated four factor prothrombin complex concentrate, approved by the U.S. FDA this summer, is indicated for the urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist therapy in adult patients with need for urgent surgery or invasive procedures.

• Align Technology Completes Acquisition of Cubicure, a Pioneer of Direct 3D Printing Solutions for Polymer Additive Manufacturing

  1/3/2024

  Align Technology, Inc. announced that it has completed the acquisition of privately-held Cubicure GmbH, a pioneer in direct 3D printing solutions for polymer additive manufacturing that develops, produces, and distributes innovative materials, equipment, and processes for novel 3D printing solutions.

• Azenta to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

  1/3/2024

  Azenta, Inc. announced that Company management will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Thursday, January 11, 2024, at 7:30 am PST.

• BiVACOR Names Veteran Medical Device Executive Jim Dillon as Chief Executive Officer

  1/3/2024

  BiVACOR, Inc., a clinical-stage medical technology company developing a total artificial heart, announced that Jim Dillon has been named chief executive officer and a member of its board of directors.

• Stevanato Group to Present at the 42nd Annual J.P. Morgan Healthcare Conference

  1/3/2024

  Stevanato Group S.p.A. announced that it will participate in the 42nd Annual J.P. Morgan Healthcare Conference taking place from January 8, 2024 to January 11, 2024 in San Francisco, California.

• ValGenesis VLMS to Drive Digital Transformation for Leading Spanish Pharmaceutical Company

  1/2/2024

  ValGenesis, Inc. announced that a leading Spanish pharmaceutical company selected ValGenesis VLMS – the industry's most trusted electronic validation lifecycle management system – to digitize its corporate validation process.

• Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas

  1/2/2024

  Psychemedics Corporation proudly announces the relocation of its corporate headquarters from Acton, Massachusetts, to Dallas, Texas, while reaffirming its unwavering dedication to delivering exceptional service and maintaining the highest standards in hair drug testing.

• Vesica Health to Present at the Seed Showcase, Part of Biotech Showcase, The Investor Conference for Innovators

  1/2/2024

  VESICA HEALTH, INC. announced that it has been selected to participate in the Seed Showcase, part of the 2024 Biotech Showcase™.